Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD

NCT02989935 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT02989935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02989935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD
Lead sponsor
University of Calgary
Phase
Phase 4
Overall status
Active, not recruiting
Start date
April 30, 2016
Completion date
July 1, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd